TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03795233

Fecal Microbiota Transplant for Primary CDI

Cause of deathDrug or device supply, also staffing, sites or logistics Automatic label, confidence 0.6, unverified. How labels are made.
“The study was terminated after a covid-related suspension and the unavailability of drug.”

The sponsor’s own words in the registry.

Life of this trial

20182019202020212022Registered2018-11-21Started2019-08-23Stopped2021-01-15Results posted2021-12-15

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
Boston Medical Center
Sponsor type
University, hospital or other
Conditions
Clostridium Difficile Infection
Interventions
Fecal microbiota transplant G3 capsules; Oral Vancomycin alone
Participants
5
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.